Thus, as an initial proof-of-concept study to determine whether AGPCRs may offer new targets for HF therapeutics, we generated a constitutive, CM-specific ADGRG1 knockout mouse by which to define the impact of ADGRG1 on the response to chronic cardiac stress. This evidence concerns the gene ADGRG1 and hydrops fetalis.